This page shows the latest Anaveon news and features for those working in and with pharma, biotech and healthcare.
Founders focused on IL-2 Receptor Agonists. Novartis' venture fund arm and Syncona are supporting new Switzerland-based immuno-oncology specialists Anaveon. ... re-direction of IL-2 activity in vivo, Anaveon has developed biologic approaches for the
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...